Christopher I. McHugh

Massachusetts Eye and Ear Infirmary

Papers

3

Total Citations

63

H-Index

3

About

Christopher I. McHugh is a head and neck surgical oncologist whose research focuses on optimizing outcomes for patients with HPV-related oropharyngeal squamous cell carcinoma (HPV+ OPSCC) undergoing transoral robotic surgery (TORS). His work has made critical contributions to understanding surgical margins, perioperative care, and pain management in this rapidly evolving treatment landscape. McHugh’s most cited study (44 citations) challenged conventional wisdom by demonstrating that close surgical margins may not compromise local control in HPV+ OPSCC patients treated with single-modality TORS—a finding with significant implications for de-escalation protocols. He has also advanced clinical practice by identifying predictors of feeding tube dependence (13 citations) and quantifying opioid usage patterns (6 citations) following TORS, directly informing evidence-based perioperative protocols. Through these retrospective cohort studies at academic tertiary centers, McHugh has provided surgeons with actionable data to reduce treatment-related morbidity while maintaining oncologic efficacy. His research bridges the gap between surgical technique and patient quality of life, establishing him as a thoughtful voice in the multidisciplinary management of oropharyngeal cancer.

Research Focus

Key Achievements

3
H-Index
3
Papers
63
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
Impact of surgical margins on local control in patients undergoing <scp>single‐modality</scp> transoral robotic surgery for <scp>HPV‐related</scp> oropharyngeal squamous cell carcinoma
44 citations · 2021
📈 Most Prolific Year: 2021 (2 Papers)
🤝 Key Collaborators: 22
🏛 Institutions: Massachusetts Eye and Ear Infirmary

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago